abstract |
This invention relates to an antihaemolytic liposomal preparation comprising 16#90 wt% of sulfolipids, 5#70 wt% of phosphatidyl choline, 5#40 wt% of cerebroside and 0#30 wt% of cholesterol for treating haemolysis, especially, complement-induced haemolysis. |